Achieve Life Sciences, Inc. (ACHV)
NASDAQ·Healthcare·Biotechnology
$4.27
+7.83%
Mkt Cap $224.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | — | — | — | -$0.27 | -$0.28 | -3.70% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.24 | -$0.28 | -16.67% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.37 | -$0.37 | +0.00% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.37 | -$0.37 | +0.00% | — | — |
| Q1 2025 Mar 11, 2025 | — | — | — | -$0.30 | -$0.36 | -20.00% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.26 | -$0.36 | -38.46% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.22 | -$0.25 | -13.64% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.24 | -$0.26 | -8.33% | — | — |
| Q1 2024 Mar 28, 2024 | — | — | — | -$0.32 | -$0.26 | +18.75% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.34 | -$0.34 | +0.00% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.41 | -$0.43 | -4.88% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.65 | -$0.50 | +23.08% | — | — |
| Q1 2023 Mar 16, 2023 | $100.00K | — | — | -$0.90 | -$0.83 | +7.78% | — | — |
| Q4 2022 Nov 14, 2022 | $62.50K | — | — | -$1.10 | -$1.35 | -22.73% | — | — |
| Q3 2022 Aug 11, 2022 | $62.50K | — | — | -$0.79 | -$1.08 | -36.71% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.82 | -$0.80 | +2.44% | — | — |
| Q1 2022 Mar 10, 2022 | $50.00K | — | — | -$0.73 | -$0.76 | -4.11% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$1.09 | -$0.71 | +34.86% | — | — |
| Q3 2021 Aug 11, 2021 | — | — | — | -$1.23 | -$1.53 | -24.39% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.78 | -$1.30 | -66.67% | — | — |